EUFEPS Welcomes You to Conference on the Safety Paradigm for Medicines – Changes and Challenges from Drug Discovery to Usage April 27-28, 2015, Lisbon, Portugal Sciences driven efficacy, safety and regulation is key for new and better medicines – from first discovery to end usage. The conference is a new initiative, focussing on challenges for the current medicines development and usage. It is...

The registration for the EUFEPS Annual Meeting 2015 - System Approaches for Better Medicines and Health is now open. Plea se see the conference webpage for more information.

EUFEPS will in March 2015 initiate The Global Bioequivalence Harmonisation Initiative with a scientific conference on the topic in Amsterdam, The Netherlands. Since decades, bioequivalence is considered one of the key questions in new and generic drug product development and registration worldwide. At the same time, it is obvious that the regulations and jurisdictions still differ to certain...

The documents on Horizon2020 were released on December 10, 2013. for the latest updates see: http://ec.europa.eu/programmes/horizon2020/ for the details about WP1: http://ec.europa.eu/research/participants/portal/desktop/en/funding/reference_docs.html for more background on the Horizon2020 see: http://ec.europa.eu/programmes/horizon2020/sites/horizon2020/files/281113_Horizon%202020%20standard%...

Dear Colleagues This is to invite you to two satellite events which will be organized in conjunction with the “ 7th Noordwijkerhout Symposium on Pharmacokinetics, Pharmacodynamics and Systems Pharmacology ”. These two satellite events are the Open Workshop “ Drug & Disease Model Resource (DDMoRe)”, immediately prior to the main symposium on Wednesday April 23 between 10:00 – 12:00 hrs and the...

The EUFEPS BABP Network Open Discussion Forum Revised European Guideline on Pharmacokinetic and Clinical Evaluation of Modified Release Dosage Forms was held June 17-18, 2013, Bonn, Germany. Scope & Aim Revised European guideline on modified release dosage forms has been published by the European Medicines Agency. Two years ago, in February 2011, the EUFEPS Network on Bioavailability and...